Skip to main content
OpenTrials
Completed

NCT Number: NCT04402346

Radiofrequency-assisted Transection of the Pancreas vs Stapler

Main objective: The main end-point of this study is to compare in a randomized clinical trial that radiofrequency-assisted pancreas transection (RF) reduces the incidence of postoperative pancreatic fistula (POPF) compared to the classical method of transection (stapler). As secondary end-points, other clinical and demographic variables of the patients will be evaluated (sex, age, ASA classification, consistency of the pancreas, as well as the type of procedure, open or laparoscopic surgery, estimated intraoperative bleeding, pancreatic duct size, duration of intervention, type of tumor and quality of lymphatic resection). Methodology: Phase III prospective multicenter study in patients undergoing distal pancreatectomy for any origin. All consecutive patients who undergo a distal pancreatectomy for any cause in a multicenter setting will be included. A simple randomization of the participants to the RFA group or to the control group (stapler) will be carried out. The incidence of pancreatic fistula will be assessed as main variable; predictive multivariable models with multiple regression for quantitative variables, logistic regression for categorical variables and Cox regression for survival analyzes. In addition to histological study, molecular analysis of resection specimen and clinical and radiological follow-up with volumetry of necrosis in the area of post-pancreatectomy transection will be performed.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Parc de Salut Mar de Barcelona- Hospital del Mar

Barcelona, Catalonia, 08019, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Solid or cystic, benign or malign pancreas neoplasms.
  • Patients undergoing a distal pancreatectomy, i.e pancreas transection beyond > 2 cm from the SMV (assessed by computer tomography or RM) with or without splenectomy
  • Both open and laparoscopic approaches are valid.

Exclusion criteria

  • Patients who required a pancreatectomy with transection at the level of the neck.
  • Non-intervention group: only stapler transection will be accepted, other pancreatic transection methods will be excluded.
  • Patients ASA≥IV
  • Absence of informed consent
  • Underage (<18 years)

Treatment and study plan

Radiofrequency-assisted pancreas transection

Procedure

Transection of the pancreas in distal pancreatectomy by applying a radio frequency device

Stapler assisted pancreas transection

Procedure

Transection of the pancreas in distal pancreatectomy by applying a stapler device with/without seamguard

Primary outcomes

  1. Pancreas fistula

    Time frame: 90 days follow-up

    Defined by the updated 2016 ISGPF definition

Secondary outcomes

  1. In-hospital Mortality

    Time frame: In-Hospital (30 days)

    30 days

  2. Morbidity

    Time frame: 90 days follow-up

    In terms of Clavien-Dindo and CCI classification

Sponsors and collaborators

Lead sponsor

Patricia Sanchez Velazquez

Other

Registry information

Official study title

Radiofrequency-assisted Transection of the Pancreas vs Stapler. A Phase III Randomized Clinical Trial.

Acronym: TRANSPAIRE

Important dates

Study start
2021
Primary completion
2025
Study completion
2025
First posted
May 26, 2020
Registry last updated
Jul 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.